Business
Growing Renal Therapy Market in Europe
The European renal replacement therapy market for patients with acute renal failure (ARF) is forecast to reach U.S.$226.2 million by 2011, while revenues in the end-stage renal disease (ESRD) therapy market could reach $2.1 billion in 2011, according to a new report from Frost & Sullivan More...09 Nov 2005
Rubicon and Abbott to Develop Cancer Diagnostic
A multi-year research and option agreement has been announced whereby Rubicon Genomics, Inc., and Abbott Molecular will co-develop the MethylPlex methylation detection technology of Rubicon for the diagnosis and prognosis of cancer. More...07 Nov 2005
Siemens and Impac Extend Agreement
Siemens Medical Solutions and Impac Medical Systems Inc., part of the Elekta Group and a leading provider of information technology systems for oncology care, have recently announced a five-year extension of their software distribution agreement More...03 Nov 2005
In Other News
GE Gets Distribution Rights to Blood Platform
Alliance to Develop Renal Failure Therapy
Advantages Offset High Costs of MRI
Beckman to Buy DSL, Expand Endocrine Testing
Alliance for Anticoagulation Self-Monitoring
Alliance to Develop Botanical Wound Healer
Qiagen to Acquire Chinese Biotech Firm
New Technologies Fuel EU Diagnostics Market
Hologic to Distribute Esaote MRI Systems
Quinton and Cardiac Science Complete Merger
GE to Acquire IDX for $1.2 Billion
European Diabetes Diagnostics Market
European Market for Imaging Technologies
Alliance for Ovarian Cancer Research
Dade Behring to Buy Ranbaxy Assets
Partnership Combines CAD with Mammography
Joint Venture Acquires Safety Scalpel
Olympus Acquires Advalytix
NuVasive Buys Assets From Pearsalls
Collaboration for Innovative Imaging
Philips Wins Speech Recognition Award
Abbott's Expands Presence in China
European Market for Cancer Diagnostics
HospiMedica Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the healthcare industry worldwide.







